ALPS Advisors
NUVB icon

ALPS Advisors’s Nuvation Bio NUVB Stock Holding History

ALPS Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.61M Buy
465,179
+113,184
+32% +$710K 0.01% 451
2026
Q2 		$2M Buy
351,995
+69,844
+25% +$341K 0.01% 523
2026
Q1 		$1.21M Buy
282,151
+1,251
+0.4% +$6.97K 0.01% 548
2025
Q4 		$2.52M Buy
280,900
+116,851
+71% +$724K 0.01% 357
2025
Q3 		$607K Sell
164,049
-18,986
-10% -$51.7K ﹤0.01% 634
2025
Q2 		$357K Sell
183,035
-62,091
-25% -$129K ﹤0.01% 854
2025
Q1 		$431K Sell
245,126
-27,024
-10% -$61.5K ﹤0.01% 610
2024
Q4 		$724K Buy
+272,150
New +$701K ﹤0.01% 554

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

ALPS Advisors's NUVB Position: Q3 2026 in Review

ALPS Advisors increased its Nuvation Bio (NUVB) stake by 32% in Q3 2026, buying an estimated $710K and bringing the position to 465,179 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #451.

ALPS Advisors first reported a position in NUVB in Q4 2024 and has held it in 8 quarters since. 114 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • ALPS Advisors held 465,179 shares of Nuvation Bio worth $2.61M as of Q3 2026.
  • ALPS Advisors bought 113,184 Nuvation Bio shares in Q3 2026, an estimated $710K.
  • Nuvation Bio made up 0.01% of ALPS Advisors's portfolio in Q3 2026, its #451 holding.
  • ALPS Advisors first reported a position in Nuvation Bio in Q4 2024 and has held it in 8 quarters since.
  • 114 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.